EUR/USD
1.18696
-0.013%
Gold
5058.82
-0.501%
Oil
64.620
-0.179%
USD/JPY
153.099
-0.110%
GBP/USD
1.36264
-0.012%
GBP/JPY
208.623
-0.109%
Real-time News
The preliminary figures for the UKs Q4 GDP annual rate, UK December industrial production month-on-month rate, UK December manufacturing output month-on-month rate, UK December seasonally adjusted goods trade balance, and UK December three-month GDP month-on-month rate will be released in ten minutes.Lenovo CEO: Lenovo raises PC prices to cope with soaring memory chip costs.On February 12th, Jeff Schulze of Clearbridge Investments noted in a report that the US January labor market data was positive for risk assets, as it showed a solid employment base that could further boost consumer spending. He stated that investors have postponed their expectations for a Federal Reserve rate cut from June to July, as the data indicates that the current labor market does not require additional monetary easing to maintain growth. While rising interest rates exert pressure, the improved economic growth outlook has completely offset this impact. Schulze also cautioned that although the report was generally positive, its important to note that January data is often heavily influenced by seasonal factors and may exaggerate the performance of the monthly jobs report.On February 12th, Nomura Research reported that WuXi Biologics (02269.HK) announced a profit forecast, expecting revenue to grow by 16.7% year-on-year to RMB 21.8 billion in 2025, slightly higher than the market expectation of RMB 21.5 billion. Gross margin improved by 5 percentage points year-on-year to 46%, also higher than the market expectation of 43%. Net profit and net profit attributable to shareholders increased by 45.3% and 46.3% year-on-year to RMB 5.7 billion and RMB 4.9 billion respectively, exceeding the market expectations of RMB 4.8 billion and RMB 4.4 billion. Non-IFRS net profit increased by 22% year-on-year to RMB 6.6 billion. The bank estimates that revenue in the second half of 2025 will grow by 17.2% year-on-year to RMB 11.8 billion, with profit increasing by 38%, both exceeding market expectations. Management attributed the growth to optimistic research service revenue performance and more projects entering later stages driven by improved service capabilities. The bank believes that its subsidiary, WuXi Biologics Associates (02268.HK), is a significant contributor to revenue growth. Excluding the contribution from the WuXi AppTec consortium, revenue is expected to grow by 12% year-on-year to RMB 9.9 billion in the second half of 2025, accelerating from 9% in the first half of 2025. The bank raised its target price from HK$37.36 to HK$50.54 and maintained its buy rating.On February 12th, Samsung announced that it has begun shipping the latest version of its HBM4 memory chips to customers, marking a significant milestone in the companys strategic lead in the AI memory market. Samsung is accelerating its efforts to meet strong demand for Nvidia graphics chips. Previously, competitor SK Hynix had taken a technological lead and dominated Nvidias high-bandwidth memory orders, a key component of AI accelerators. However, in recent months, Samsung has narrowed the gap with its rival.
